FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for VIGADRONE (vigabatrin) by Upsher-Smith Laboratories, LLC under ANDA 210196.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Infantile Spasms
• Tuberous Sclerosis Complex

Drugs mentioned

• VIGADRONE (VIGABATRIN)

Snippet

SUPPL AP for VIGADRONE (VIGABATRIN)